Ostatní
Návod 
Arvinas, Inc.
ARVN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.8B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-9
PS
3
Cena 1R
6-20
⌀ Cena
8.83
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
24-02-2026
Poslední dividenda
Profil
Společnost Arvinas, Inc., biofarmaceutická společnost v klinickém stadiu, se zabývá objevováním, vývojem a komercializací terapií ke znehodnocení proteinů způsobujících nemoci. Mezi jeho hlavní produkty patří Bavdegalutamid, proteolýza zaměřená na degradér proteinu chimery (PROTAC), který je ve fázi I klinické studie zaměřený na protein receptoru androgenu (AR) pro léčbu mužů s metastazujícím kastračně rezistentním karcinomem prostaty (mCRPC); ARV-471, degradér proteinu PROTAC zaměřený na protein receptoru estrogenu pro léčbu pacientů s metastazujícím ER pozitivním/HER2 negativním karcinomem prsu; a ARV-766 hodnocený perorálně biologicky dostupný degradér proteinu PROTAC pro léčbu mužů CRPC. Společnost spolupracuje se společnostmi Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd. a Bayer AG. Společnost Arvinas, Inc. byla založena v roce 2013 a sídlí v New Havenu v Connecticutu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
430
Založení
2018-09-27
Podobné společnosti
$ 8.71
- $ 0.02
$ 10.02
+ $ 0.29
$ 8.66
+ $ 0.35
$ 8.71
+ $ 0.24
$ 2.48
+ $ 0.18
$ 1.11
+ $ 0.04
$ 8.94
- $ 0.01
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 262.6 | 262.6 | 263.4 | 78.5 | 131.4 | 46.7 | 21.8 | 43.0 | 14.3 | 7.6 | 6.7 | |
| Cost of Revenues | 1.2 | 5.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 261.4 | 257.4 | 263.4 | 78.5 | 131.4 | 46.7 | 21.8 | 43.0 | 14.3 | 7.6 | 6.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 9.5 | 41.9 | 22.4 | 188.8 | 59.2 | 102.4 | 76.5 | 25.3 | -43.1 | 34.6 | |
| Cost of Revenues | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.7 | 1.7 | 1.7 | 1.7 | |
| Gross Profit | 8.3 | 41.9 | 22.4 | 188.8 | 59.2 | 102.4 | 74.8 | 23.6 | -44.8 | 32.9 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 379.7 | 315.0 | 180.4 | 108.4 | 67.2 | 45.2 | 28.8 | 19.9 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 100.3 | 79.6 | 61.6 | 38.3 | 27.3 | 12.9 | 3.5 | 3.2 | |
| Depreciation & Amortization | 4.7 | 5.2 | 6.6 | 6.7 | 8.2 | 6.0 | 4.0 | 2.3 | 0.7 | 0.3 | 0.4 | |
| Total Operating Expenses | 377.0 | 372.3 | 513.6 | 480.0 | 394.6 | 242.0 | 146.7 | 94.5 | 58.1 | 32.3 | 23.1 | |
| Operating Income | -115.6 | -114.9 | -250.2 | -401.5 | -263.2 | -195.3 | -124.9 | -51.5 | -43.8 | -24.8 | -16.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 95.2 | 85.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.3 | 22.6 | ||
| Depreciation & Amortization | 1.2 | 0.8 | 1.4 | 1.3 | 1.6 | 1.1 | 1.7 | 1.7 | 1.7 | 1.7 | ||
| Total Operating Expenses | 80.0 | 85.7 | 93.9 | 117.4 | 117.4 | 162.7 | 123.3 | 106.9 | 120.5 | 108.5 | ||
| Operating Income | -71.7 | -43.8 | -71.5 | 71.4 | -58.2 | -60.3 | -48.5 | -83.3 | -165.3 | -73.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 40.0 | 22.0 | 54.8 | 38.8 | 12.2 | 4.3 | 5.5 | 5.9 | 2.3 | 0.2 | 0.4 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 12.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Other Expense | 35.2 | 34.4 | 51.9 | 37.6 | 12.2 | 4.3 | 5.5 | -18.8 | -0.1 | 0.6 | 1.7 | |
| IBT | -80.4 | -80.5 | -198.3 | -363.9 | -251.0 | -191.0 | -119.3 | -70.3 | -41.5 | -24.0 | -14.4 | |
| Income Tax Expense | 0.4 | 0.3 | 0.6 | 0.9 | 20.9 | -7.8 | -7.5 | -8.2 | 2.4 | 0.6 | -0.1 | |
| Net Income | -80.8 | -80.8 | -198.9 | -367.3 | -271.9 | -183.2 | -111.8 | -62.1 | -41.5 | -24.0 | -14.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.0 | 9.0 | 10.3 | 11.7 | 12.9 | 14.3 | 13.6 | 14.0 | 12.2 | 10.0 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.1 | 0.0 | ||
| Other Expense | 4.5 | 9.0 | 10.0 | 11.7 | 12.7 | 11.7 | 13.5 | 14.0 | 12.1 | 10.0 | ||
| IBT | -67.2 | -34.8 | -61.5 | 83.1 | -45.5 | -48.6 | -35.0 | -69.3 | -153.2 | -63.9 | ||
| Income Tax Expense | 0.2 | 0.3 | -0.3 | 0.2 | -0.4 | 0.6 | 0.2 | 0.1 | 1.6 | 0.1 | ||
| Net Income | -67.4 | -35.1 | -61.2 | 82.9 | -45.1 | -49.2 | -35.2 | -69.4 | -154.8 | -64.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-6.62 | $-5.11 | $-3.66 | $-2.83 | $-1.89 | $-4.40 | $-1.16 | $-0.80 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-6.62 | $-5.11 | $-3.66 | $-2.83 | $-1.89 | $-4.40 | $-1.16 | $-0.80 | |
| Shares Outstanding | 64.9 | 64.9 | 71.9 | 55.5 | 53.2 | 50.0 | 39.5 | 32.9 | 9.4 | 20.7 | 17.9 | |
| Diluted Shares Outstanding | 64.9 | 64.9 | 71.9 | 55.5 | 53.2 | 50.0 | 39.5 | 32.9 | 9.4 | 20.7 | 17.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-2.53 | $-1.18 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-2.53 | $-1.18 | ||
| Shares Outstanding | 64.9 | 72.9 | 72.8 | 72.5 | 72.1 | 72.1 | 71.9 | 71.7 | 61.1 | 54.1 | ||
| Diluted Shares Outstanding | 64.9 | 72.9 | 73.0 | 72.7 | 72.1 | 72.1 | 71.9 | 71.7 | 61.1 | 54.1 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 160.3 | 100.5 | 311.7 | 81.3 | 108.3 | 588.4 | 9.2 | 3.2 | 30.9 | 5.1 | |
| Short Term Investments | 1,073.9 | 938.9 | 949.3 | 1,124.0 | 1,394.3 | 100.2 | 271.7 | 184.6 | 8.3 | 30.5 | |
| Total Cash & ST Investments | 1,234.2 | 1,039.4 | 1,261.0 | 1,205.3 | 1,502.6 | 688.5 | 280.9 | 187.8 | 39.2 | 35.6 | |
| Accounts Receivable | 10.0 | 13.7 | 7.2 | 8.0 | 25.7 | 8.4 | 6.3 | 5.0 | 26.0 | 1.4 | |
| Inventory | 0.0 | 0.0 | 0.0 | 5.5 | 4.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 12.5 | 14.2 | 12.0 | 21.4 | 19.7 | 6.1 | 3.7 | 2.8 | 0.3 | 0.3 | |
| Total Current Assets | 1,256.7 | 1,067.3 | 1,280.2 | 1,240.2 | 1,552.5 | 703.1 | 290.9 | 195.7 | 65.5 | 37.3 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 101.5 | 114.9 | 81.0 | 100.5 | 85.2 | 154.8 | 88.0 | 317.2 | 113.7 | 90.6 | |
| Short Term Investments | 686.1 | 746.3 | 873.3 | 938.9 | 1,036.4 | 1,073.9 | 1,081.3 | 949.3 | 884.8 | 948.2 | |
| Total Cash & ST Investments | 787.6 | 861.2 | 954.3 | 1,039.4 | 1,121.6 | 1,228.7 | 1,169.3 | 1,266.5 | 998.5 | 1,038.8 | |
| Accounts Receivable | 26.8 | 11.1 | 8.4 | 13.7 | 14.8 | 10.0 | 7.1 | 7.2 | 20.6 | 4.8 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.5 | 5.5 | |
| Other Current Assets | 11.9 | 17.2 | 17.0 | 14.2 | 13.1 | 18.0 | 13.9 | 12.0 | 13.9 | 13.1 | |
| Total Current Assets | 826.3 | 889.5 | 979.7 | 1,067.3 | 1,149.5 | 1,256.7 | 1,190.3 | 1,280.2 | 1,033.0 | 1,056.7 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 11.3 | 16.0 | 14.0 | 17.8 | 16.6 | 14.3 | 10.7 | 3.6 | 1.3 | 0.6 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 11.6 | 8.1 | 10.4 | 10.8 | 12.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 22.9 | 24.1 | 24.4 | 28.6 | 29.1 | 14.3 | 10.8 | 3.6 | 1.3 | 0.7 | |
| Total Assets | 1,279.6 | 1,091.4 | 1,304.6 | 1,268.8 | 1,581.6 | 717.4 | 301.6 | 199.3 | 66.8 | 37.9 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 14.1 | 15.4 | 16.6 | 16.0 | 7.8 | 11.3 | 12.4 | 14.0 | 15.7 | 16.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 3.9 | 4.4 | 4.8 | 8.1 | 9.8 | 11.6 | 9.9 | 10.4 | 9.6 | 10.1 | |
| Total Long-Term Assets | 18.0 | 19.8 | 21.4 | 24.1 | 17.6 | 22.9 | 22.3 | 24.4 | 25.3 | 26.8 | |
| Total Assets | 844.3 | 909.3 | 1,001.1 | 1,091.4 | 1,167.1 | 1,279.6 | 1,212.6 | 1,304.6 | 1,058.3 | 1,083.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 23.0 | 13.4 | 17.8 | 5.7 | 31.3 | 7.1 | 4.6 | 2.8 | 0.6 | 1.6 | |
| Short-Term Debt | 1.4 | 1.8 | 1.9 | 1.8 | 1.1 | 1.0 | 0.7 | 0.2 | 0.2 | 0.1 | |
| Other Current Liabilities | 54.9 | 55.2 | 73.7 | 69.0 | 23.1 | 18.9 | 7.6 | 4.0 | 3.5 | 1.7 | |
| Current Liabilities | 347.2 | 229.8 | 257.1 | 295.1 | 261.7 | 49.1 | 32.8 | 23.0 | 17.9 | 10.0 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 17.8 | 16.6 | 26.4 | 13.4 | 17.7 | 23.2 | 17.8 | 17.8 | 34.3 | 6.7 | |
| Short-Term Debt | 1.9 | 1.8 | 1.9 | 1.8 | 0.8 | 1.2 | 1.5 | 1.9 | 4.0 | 3.9 | |
| Other Current Liabilities | 37.5 | 33.2 | 41.2 | 55.2 | 54.1 | 51.5 | 55.2 | 73.7 | 53.7 | 65.2 | |
| Current Liabilities | 144.9 | 157.8 | 214.0 | 229.8 | 275.9 | 347.2 | 240.8 | 257.1 | 317.3 | 306.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.7 | 7.9 | 1.3 | 3.7 | 3.9 | 3.1 | 3.7 | 2.0 | 0.2 | 0.3 | |
| Capital Leases | 0.2 | 9.1 | 2.4 | 4.5 | 4.0 | 2.0 | 2.4 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | -331.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -61.4 | -56.9 | |
| Total Liabilities | 679.4 | 529.7 | 644.6 | 703.9 | 799.9 | 75.1 | 75.0 | 62.6 | 66.6 | 13.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 7.6 | 8.1 | 8.6 | 7.9 | 0.7 | 0.9 | 1.1 | 1.3 | 1.9 | 2.5 | |
| Capital Leases | 0.0 | 9.4 | 10.0 | 9.1 | 0.9 | 1.4 | 1.9 | 0.5 | 3.0 | 3.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.9 | |
| Total Liabilities | 279.9 | 300.0 | 341.0 | 529.7 | 581.1 | 679.5 | 602.9 | 644.6 | 601.1 | 619.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 0.9 | |
| Retained Earnings | -1,437.3 | -1,531.6 | -1,332.7 | -965.4 | -682.9 | -491.9 | -372.6 | -302.3 | -62.4 | -33.8 | |
| Comprehensive Income | -3.8 | 1.0 | -3.1 | -19.2 | -4.6 | 0.6 | 0.1 | -0.2 | 0.0 | 0.0 | |
| Total Common Equity | 600.2 | 561.7 | 660.0 | 564.9 | 781.7 | 642.3 | 226.7 | 136.7 | 0.2 | 24.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -1,545.0 | -1,509.9 | -1,448.7 | -1,531.6 | -1,486.5 | -1,437.3 | -1,402.1 | -1,332.7 | -1,177.9 | -1,113.9 | |
| Comprehensive Income | 1.4 | 1.0 | 1.5 | 1.0 | 4.1 | -3.8 | -4.4 | -3.1 | -9.2 | -12.2 | |
| Total Common Equity | 564.4 | 609.3 | 660.1 | 561.7 | 586.0 | 600.1 | 609.7 | 660.0 | 457.2 | 463.6 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 2.3 | 9.7 | 3.2 | 5.5 | 5.0 | 4.0 | 4.4 | 2.2 | 0.3 | 0.5 | |
| Book Value | 600.2 | 561.7 | 660.0 | 564.9 | 781.7 | 642.3 | 226.7 | 136.7 | 0.2 | 24.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 564.4 | 609.3 | 660.1 | 561.7 | 586.0 | 600.1 | 609.7 | 660.0 | 457.2 | 463.6 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -323.4 | -80.8 | -198.9 | -367.3 | -282.5 | -191.0 | -119.3 | -70.3 | -41.5 | -24.0 | -14.4 | |
| Depreciation & Amortization | 6.8 | 5.2 | 6.6 | 6.7 | 8.2 | 6.0 | 4.0 | 2.3 | 0.7 | 0.3 | 0.4 | |
| Stock-Based Compensation | 73.6 | 44.0 | 88.2 | 71.6 | 75.5 | 57.1 | 30.2 | 20.1 | 11.6 | 0.2 | 0.5 | |
| Change Working Capital | 47.2 | -233.7 | -140.6 | -44.4 | -82.6 | 678.3 | -5.9 | 7.2 | 12.6 | 28.2 | -5.6 | |
| Change In Accounts Receivable | -5.1 | 7.3 | -5.7 | 0.8 | 14.0 | -14.0 | -1.0 | 2.8 | 22.2 | -25.0 | 0.0 | |
| Change In Accounts Payable | 4.0 | -1.7 | -21.2 | 17.3 | 20.2 | 23.7 | 2.0 | 1.6 | 2.0 | -1.0 | 1.2 | |
| Change In Inventories | 8.2 | 0.0 | 0.0 | 0.0 | 0.0 | -26.9 | 6.3 | -2.1 | -3.3 | 2.3 | 0.0 | |
| Other Non-cash Items | 51.0 | -8.5 | -14.6 | -14.4 | 7.9 | 9.8 | 1.7 | 0.2 | 0.3 | 0.4 | 0.6 | |
| Cash from Operations | -215.1 | 0.0 | 0.0 | -347.8 | -273.5 | 559.4 | -89.8 | -40.6 | -16.1 | 5.1 | -19.4 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -67.4 | -35.1 | -61.2 | 82.9 | -45.1 | -49.2 | -35.2 | -69.4 | -154.8 | -64.0 | |
| Depreciation & Amortization | 1.2 | 1.3 | 1.4 | 1.3 | 1.6 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | |
| Stock-Based Compensation | 8.5 | 0.0 | 10.3 | 15.0 | 23.3 | 24.7 | 21.6 | 18.6 | 16.7 | 16.7 | |
| Change Working Capital | 29.5 | -32.8 | -42.8 | -187.6 | -60.2 | -103.7 | 66.6 | -43.3 | 59.0 | -35.1 | |
| Change In Accounts Receivable | 20.4 | -15.7 | -2.7 | 5.3 | 1.1 | -4.8 | -2.9 | 0.1 | 13.3 | -15.6 | |
| Change In Accounts Payable | 16.0 | -0.1 | -16.8 | 0.0 | 0.0 | 0.0 | 1.8 | -15.7 | 1.3 | 16.6 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.8 | -16.6 | |
| Other Non-cash Items | -2.2 | 7.5 | -3.1 | -0.5 | -3.7 | -1.4 | -4.4 | -5.1 | -0.2 | -3.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -83.1 | -84.8 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.0 | -1.9 | -1.8 | -2.9 | -6.8 | -4.7 | -6.4 | -6.2 | -2.8 | -1.0 | -0.3 | |
| Acquisitions | -17.4 | 0.0 | 0.1 | 0.0 | 0.4 | 0.2 | -395.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Investments | -904.4 | -354.2 | -652.1 | -956.3 | -886.4 | -1,744.6 | -41.2 | -256.5 | -234.9 | -3.2 | -36.7 | |
| Sales of Investment | 807.9 | 763.7 | 688.5 | 1,162.7 | 1,136.0 | 435.7 | 211.9 | 169.7 | 58.1 | 25.1 | 16.9 | |
| Other Investing Activities | -110.2 | 0.0 | 0.0 | 0.0 | -0.4 | -0.2 | 395.1 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Cash from Investing | -98.4 | 0.0 | 0.0 | 203.5 | 242.8 | -1,313.6 | 164.3 | -93.1 | -179.7 | 20.9 | -20.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.2 | -0.1 | -1.2 | -0.4 | -0.3 | -0.7 | -0.7 | -0.1 | -0.1 | -1.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 53.6 | -71.1 | |
| Investments | -6.6 | -110.0 | -118.0 | -119.6 | -51.3 | -160.4 | -192.5 | -247.9 | -290.6 | -173.4 | |
| Sales of Investment | 152.6 | 173.6 | 248.0 | 189.5 | 150.5 | 211.6 | 206.2 | 120.2 | 237.0 | 244.5 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -53.6 | 71.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -53.7 | 70.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.2 | -0.2 | -0.1 | |
| Debt Issued | -1.9 | 9.7 | 6.5 | -2.3 | 0.5 | 1.0 | -0.3 | 2.4 | 2.0 | 0.0 | 0.6 | |
| Issuance of Common Stock | 378.0 | 0.0 | 0.0 | 387.2 | 4.7 | 264.6 | 525.6 | 137.7 | 114.6 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | -91.9 | 0.0 | 0.0 | 0.0 | 0.0 | -29.2 | -0.6 | -3.4 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.4 | -60.5 | 0.0 | 0.0 | |
| Other Financing Activities | 23.8 | 0.0 | 0.0 | 0.0 | 0.0 | 14.0 | 8.3 | 6.2 | 117.6 | 0.0 | 0.0 | |
| Cash from Financing | 377.7 | 0.0 | 0.0 | 374.7 | 4.7 | 278.6 | 504.7 | 139.7 | 168.1 | -0.2 | -0.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 9.5 | -0.4 | -0.6 | 0.8 | 8.2 | -0.6 | -0.5 | -0.8 | -0.6 | -0.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 350.1 | 37.9 | |
| Repurchase of Common Stock | -74.1 | -17.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.3 | 37.9 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 334.8 | 37.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 64.2 | 42.4 | -216.7 | 230.4 | -26.0 | -475.6 | 579.2 | 6.0 | -27.7 | 25.8 | -39.7 | |
| Closing Cash Balance | 160.3 | 142.9 | 100.5 | 317.2 | 86.8 | 112.8 | 588.4 | 9.2 | 3.2 | 30.9 | 5.1 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 41.4 | -13.4 | 33.9 | -19.5 | 15.3 | -75.1 | 66.8 | -223.7 | 198.0 | 23.1 | |
| Closing Cash Balance | 142.9 | 101.5 | 114.9 | 81.0 | 100.5 | 85.2 | 160.3 | 93.5 | 317.2 | 119.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -217.1 | -275.7 | -261.1 | -350.7 | -280.3 | 554.7 | -96.2 | -46.9 | -18.9 | 4.1 | -19.7 | |
| Real Free Cash Flow | -290.7 | -319.7 | -349.3 | -422.3 | -355.8 | 497.6 | -126.4 | -66.9 | -30.6 | 3.9 | -20.2 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -30.6 | -59.2 | -96.6 | -89.3 | -84.4 | -128.7 | 49.6 | -97.6 | -83.2 | -85.9 | |
| Real Free Cash Flow | -39.1 | -59.2 | -106.9 | -104.3 | -107.7 | -153.4 | 28.0 | -116.2 | -99.9 | -102.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -8.8 | -13.4 | -1.4 |
| P/S | 2.7 | 47.2 | 9.4 |
| P/B | 1.3 | 4.7 | 5.2 |
| P/FCF | -2.3 | -6.5 | -1.5 |
| Market cap | $0.8 | $1.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 0.8 % | 0 % |
| Debt to Income | -11.8 % | -4.5 % | 0 % |
| Debt to Free cash flow | -3.1 % | -2596.3 % | 0 % |
| Interest expense percentage | 0 % | -0.5 % | 44.7 % |
| Current ratio | 5.7 | 6.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -14.3 % | -168.6 % | 0 % |
| ROA | -9.6 % | -20.2 % | 0 % |
| CapEx to Revenue | 0 % | 10.9 % | 0 % |
| RaD to Revenue | 0 % | 300.5 % | 0 % |
| ROEM | 610,697.7 | 145430.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | -151.8 % | 91.5 % | 68.7 % |
| Operating margin | -45.1 % | -300.2 % | 35.5 % |
| Net margin | -30.8 % | -290.3 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 64.9 mil | 48.6 mil |
| Employee count | 0.4 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
